The revised lawsuit requests new restrictions, including to outlaw the medication for anyone under 18, targeting telemedicine practices for abortion pills.
The FDA made substantial regulatory changes since 2016, greatly expanding access to mifepristone, a medication now used in nearly two-thirds of abortions.
Decades of research shows that abortion pills are overwhelmingly safe, with serious complications being rare; however, litigation continues to challenge their accessibility.
The Supreme Court previously dismissed a related lawsuit, stating plaintiffs lacked standing, yet the case has been revived with new claims by state attorneys general.
Collection
[
|
...
]